Ginkgo Biloba Tinnitus: Research, Benefits & Guide

Tinnitus — the perception of ringing, buzzing, or other phantom sounds in the ears — affects millions of people worldwide and can significantly diminish quality of life. The connection between Ginkgo Biloba tinnitus management has been a subject of scientific inquiry for decades, driven by the extract's well-documented ability to promote blood flow to microvascular beds, including those serving the inner ear.

Ginkgo Biloba is one of the oldest living tree species on Earth, traceable back more than 200 million years. Its medicinal use was first recorded in the Chinese Materia Medica Shen Nong Ben Cao Jing approximately 2,000 years ago. Today, standardized leaf extracts — most notably the pharmaceutical-grade EGb 761 — rank among the most widely used herbal medicines in the world and are the subject of extensive scientific study.

Ginkgo Biloba acts to increase blood flow throughout the body, and its active compounds — flavonol glycosides and terpene trilactones — deliver antioxidant, anti-inflammatory, and vasodilatory effects that researchers believe may be relevant to ear health. Because of the wide variation of ginkgo products on the market, standardization is essential to ensure maximum quality and potency.

The rationale behind studying Ginkgo Biloba tinnitus treatment centers on the extract's established mechanisms of action: improving microcirculation, antagonizing platelet-activating factor (PAF), scavenging free radicals, and protecting neuronal tissue from ischemic damage. These mechanisms are believed to address some of the underlying vascular and oxidative contributors to tinnitus.

Clinical Trial Evidence

There is evidence of efficacy for the standardized extract EGb 761 in the treatment of tinnitus from three trials in patients in whom tinnitus was the primary complaint. Supportive evidence comes from a further five trials in patients with age-associated cognitive impairment or dementia in whom tinnitus was present as a concomitant symptom.

In one randomized, double-blind trial, patients with sub-chronic or chronic tinnitus were randomized to receive 120 mg EGb 761 or 600 mg pentoxifylline, each twice daily in a double-dummy fashion over a 12-week period. For both treatment groups, significant improvements were observed in tinnitus loudness, annoyance, and overall suffering, with no relevant difference between the two groups. The incidence of adverse events was lower in the EGb 761 group.

A more recent multicentre, open-label, exploratory clinical trial examined EGb 761 in chronic tinnitus. At week 24, significant improvements were observed in all tinnitus-related outcomes compared to baseline. Notably, patients with normal hearing and/or concomitant anxiety and/or stress improved more, suggesting the therapy may be particularly beneficial for these subgroups. The overall response rate — defined as at least a 30% score reduction in three out of four outcomes — was 18.8%.

It is important to note that the efficacy of other ginkgo preparations has not been proven for tinnitus, which does not necessarily indicate ineffectiveness but may be due to flawed clinical trials. This underscores the importance of using a properly standardized extract.

Research suggests that impaired blood flow to the cochlea and auditory nerve may play a role in many cases of tinnitus. Ginkgo Biloba's primary mechanisms of action are directly relevant to these pathways:

• Vasoregulation and improved blood flow: Ginkgo Biloba improves perfusion in different vascular beds without significantly affecting blood pressure and heart rate. Multiple RCTs demonstrate improved blood flow across coronary, cerebral, cutaneous, and peripheral circulation.
• Platelet-activating factor (PAF) antagonism: Ginkgolide B is the most potent known naturally occurring inhibitor of PAF, a key mediator of anti-aggregatory and anti-inflammatory effects. This may help reduce microvascular obstruction in the delicate vessels of the inner ear.
• Antioxidant protection: The flavonol glycosides in ginkgo serve as potent free-radical scavengers, protecting neuronal and cardiovascular cells from reactive oxygen species (ROS)-mediated damage — especially important for the brain, retina, and cardiovascular system.
• Neuroprotection: Ingredients of ginkgo leaves exert appreciable blood-brain barrier-crossing efficacy and have direct effects against necrosis and apoptosis of neurons, improving neural plasticity as evidenced in vestibular compensation studies.

These overlapping mechanisms help explain why Ginkgo Biloba has attracted sustained research interest for Ginkgo Biloba tinnitus applications.

Based on the available research, Ginkgo Biloba may be most relevant for the following groups experiencing tinnitus:

• Adults with chronic or sub-chronic tinnitus: Clinical trials have specifically evaluated standardized ginkgo extract in patients with ongoing tinnitus as their primary complaint, showing significant improvements in loudness and annoyance over 12–24 weeks.
• Those with normal hearing and tinnitus: The exploratory trial found that patients with normacusis (normal hearing) improved more with EGb 761 treatment than those with hearing loss.
• Individuals with tinnitus and concurrent anxiety or stress: Subgroup analyses showed that patients with high baseline anxiety or stress responded particularly well to ginkgo treatment. Research also suggests ginkgo extract may independently help support a calmer mental state.
• Older adults with tinnitus and cognitive concerns: Five supporting trials demonstrated improvements in tinnitus as a concomitant symptom among patients with age-associated cognitive impairment or dementia.

Anyone seeking support for circulation, memory, focus, and concentration may also benefit from Ginkgo Biloba, as these are among its most well-researched applications.

Take one (1) vegetarian capsule, two (2) times daily with meals. Each capsule contains 120 mg of standardized Ginkgo Biloba leaf extract in a 50:1 concentrate.

This product provides optimal levels of naturally occurring flavonglycosides and terpene lactones and has been standardized under strict European quality standards, which are comparable to over-the-counter drug standards in the United States.

The product is gluten free, dairy free, soy free, and grain free.

Important safety considerations: Ginkgo may increase the risk of bleeding in people who are taking anticoagulant drugs such as warfarin. Ginkgo may be unsafe for use during pregnancy. Consult a healthcare professional before use if you are taking medications, particularly anticoagulants, antiplatelet drugs, or efavirenz.